pubmed-article:18620949 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18620949 | lifeskim:mentions | umls-concept:C1516985 | lld:lifeskim |
pubmed-article:18620949 | lifeskim:mentions | umls-concept:C0278882 | lld:lifeskim |
pubmed-article:18620949 | lifeskim:mentions | umls-concept:C0302523 | lld:lifeskim |
pubmed-article:18620949 | lifeskim:mentions | umls-concept:C0700325 | lld:lifeskim |
pubmed-article:18620949 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
pubmed-article:18620949 | lifeskim:mentions | umls-concept:C0796545 | lld:lifeskim |
pubmed-article:18620949 | lifeskim:mentions | umls-concept:C0677850 | lld:lifeskim |
pubmed-article:18620949 | lifeskim:mentions | umls-concept:C0282461 | lld:lifeskim |
pubmed-article:18620949 | lifeskim:mentions | umls-concept:C1521996 | lld:lifeskim |
pubmed-article:18620949 | lifeskim:mentions | umls-concept:C0205088 | lld:lifeskim |
pubmed-article:18620949 | pubmed:issue | 9633 | lld:pubmed |
pubmed-article:18620949 | pubmed:dateCreated | 2008-7-14 | lld:pubmed |
pubmed-article:18620949 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18620949 | pubmed:abstractText | Any benefit of adjuvant interferon alfa-2b for melanoma could depend on dose and duration of treatment. Our aim was to determine whether pegylated interferon alfa-2b can facilitate prolonged exposure while maintaining tolerability. | lld:pubmed |
pubmed-article:18620949 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18620949 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18620949 | pubmed:language | eng | lld:pubmed |
pubmed-article:18620949 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18620949 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:18620949 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18620949 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18620949 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18620949 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18620949 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18620949 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18620949 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18620949 | pubmed:month | Jul | lld:pubmed |
pubmed-article:18620949 | pubmed:issn | 1474-547X | lld:pubmed |
pubmed-article:18620949 | pubmed:author | pubmed-author:EORTC... | lld:pubmed |
pubmed-article:18620949 | pubmed:author | pubmed-author:EggermontAlex... | lld:pubmed |
pubmed-article:18620949 | pubmed:author | pubmed-author:DummerReinhar... | lld:pubmed |
pubmed-article:18620949 | pubmed:author | pubmed-author:KeilholzUlric... | lld:pubmed |
pubmed-article:18620949 | pubmed:author | pubmed-author:SpatzAlainA | lld:pubmed |
pubmed-article:18620949 | pubmed:author | pubmed-author:SantinamiMari... | lld:pubmed |
pubmed-article:18620949 | pubmed:author | pubmed-author:GoreMartinM | lld:pubmed |
pubmed-article:18620949 | pubmed:author | pubmed-author:PuntCornelis... | lld:pubmed |
pubmed-article:18620949 | pubmed:author | pubmed-author:SuciuStefanS | lld:pubmed |
pubmed-article:18620949 | pubmed:author | pubmed-author:HauschildAxel... | lld:pubmed |
pubmed-article:18620949 | pubmed:author | pubmed-author:TestoriAlessa... | lld:pubmed |
pubmed-article:18620949 | pubmed:author | pubmed-author:MackieRonaR | lld:pubmed |
pubmed-article:18620949 | pubmed:author | pubmed-author:KruitWim H... | lld:pubmed |
pubmed-article:18620949 | pubmed:author | pubmed-author:KusicZvonkoZ | lld:pubmed |
pubmed-article:18620949 | pubmed:author | pubmed-author:MusatElenaE | lld:pubmed |
pubmed-article:18620949 | pubmed:author | pubmed-author:MarsdenJeremy... | lld:pubmed |
pubmed-article:18620949 | pubmed:author | pubmed-author:SalèsFrançois... | lld:pubmed |
pubmed-article:18620949 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:18620949 | pubmed:day | 12 | lld:pubmed |
pubmed-article:18620949 | pubmed:volume | 372 | lld:pubmed |
pubmed-article:18620949 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18620949 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18620949 | pubmed:pagination | 117-26 | lld:pubmed |
pubmed-article:18620949 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
pubmed-article:18620949 | pubmed:meshHeading | pubmed-meshheading:18620949... | lld:pubmed |
pubmed-article:18620949 | pubmed:meshHeading | pubmed-meshheading:18620949... | lld:pubmed |
pubmed-article:18620949 | pubmed:meshHeading | pubmed-meshheading:18620949... | lld:pubmed |
pubmed-article:18620949 | pubmed:meshHeading | pubmed-meshheading:18620949... | lld:pubmed |
pubmed-article:18620949 | pubmed:meshHeading | pubmed-meshheading:18620949... | lld:pubmed |
pubmed-article:18620949 | pubmed:meshHeading | pubmed-meshheading:18620949... | lld:pubmed |
pubmed-article:18620949 | pubmed:meshHeading | pubmed-meshheading:18620949... | lld:pubmed |
pubmed-article:18620949 | pubmed:meshHeading | pubmed-meshheading:18620949... | lld:pubmed |
pubmed-article:18620949 | pubmed:meshHeading | pubmed-meshheading:18620949... | lld:pubmed |
pubmed-article:18620949 | pubmed:meshHeading | pubmed-meshheading:18620949... | lld:pubmed |
pubmed-article:18620949 | pubmed:meshHeading | pubmed-meshheading:18620949... | lld:pubmed |
pubmed-article:18620949 | pubmed:meshHeading | pubmed-meshheading:18620949... | lld:pubmed |
pubmed-article:18620949 | pubmed:meshHeading | pubmed-meshheading:18620949... | lld:pubmed |
pubmed-article:18620949 | pubmed:meshHeading | pubmed-meshheading:18620949... | lld:pubmed |
pubmed-article:18620949 | pubmed:meshHeading | pubmed-meshheading:18620949... | lld:pubmed |
pubmed-article:18620949 | pubmed:meshHeading | pubmed-meshheading:18620949... | lld:pubmed |
pubmed-article:18620949 | pubmed:meshHeading | pubmed-meshheading:18620949... | lld:pubmed |
pubmed-article:18620949 | pubmed:year | 2008 | lld:pubmed |
pubmed-article:18620949 | pubmed:articleTitle | Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial. | lld:pubmed |
pubmed-article:18620949 | pubmed:affiliation | Erasmus University Medical Center, Rotterdam, Netherlands. a.m.m.eggermont@erasmusmc.nl | lld:pubmed |
pubmed-article:18620949 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:18620949 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:18620949 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:18620949 | pubmed:publicationType | Multicenter Study | lld:pubmed |
pubmed-article:18620949 | pubmed:publicationType | Clinical Trial, Phase III | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18620949 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18620949 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18620949 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18620949 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18620949 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18620949 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18620949 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18620949 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18620949 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18620949 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18620949 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18620949 | lld:pubmed |